Jun 3, 2026 04:09PM
Jun 3, 2026 04:05PM
Jun 1, 2026 08:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM
May 22, 2026 05:15PM
May 21, 2026 08:05AM Iovance Biotherapeutics to Present at Upcoming Conference
May 7, 2026 07:05AM
Apr 27, 2026 08:01AM
Apr 17, 2026 05:15PM
Apr 10, 2026 01:20PM
Mar 20, 2026 05:15PM
Feb 26, 2026 08:00AM
Feb 24, 2026 07:00AM Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Feb 24, 2026 07:00AM
Feb 20, 2026 05:15PM
Feb 11, 2026 04:05PM
Feb 5, 2026 05:15PM
Feb 5, 2026 05:15PM
Jan 16, 2026 05:15PM
Dec 19, 2025 05:15PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nov 21, 2025 05:15PM
Nov 6, 2025 08:00AM
Nov 3, 2025 07:01AM
Nov 3, 2025 07:00AM
Oct 23, 2025 04:05PM
Oct 17, 2025 05:15PM
Sep 19, 2025 05:00PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aug 29, 2025 08:30AM
Aug 22, 2025 05:15PM
Aug 18, 2025 04:15PM
Aug 18, 2025 04:15PM
Aug 7, 2025 04:01PM
Jul 24, 2025 04:05PM
Jul 22, 2025 08:50AM Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'
Jul 18, 2025 05:15PM
Jul 15, 2025 07:31AM
Jul 15, 2025 07:30AM
Jul 14, 2025 07:30AM
Jul 14, 2025 07:30AM
Jul 10, 2025 04:01PM
Jun 30, 2025 12:02PM Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
Jun 27, 2025 12:00PM
Jun 25, 2025 12:02PM
Jun 23, 2025 04:05PM
Jun 23, 2025 12:02PM
Jun 20, 2025 12:02PM
Jun 18, 2025 12:02PM
Jun 16, 2025 12:02PM Scott+Scott Attorneys at Law LLP Again Alerts Investors of The Pending Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
Jun 13, 2025 12:02PM

322,966 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All